Helping Patients Heal Faster

Isto Biologics is a 100% biologics-focused company dedicated to helping patients heal faster. We take pride in our customer partnerships and are committed to bringing procedural expertise and cost-effective solutions to better treat patient needs.

isto icon.png

Guiding Principles

Success demands greater effort

Do better. Be better. We set our goals to reach the highest standards - and when we succeed in reaching them, we reset the bar higher. When everyone embraces that mindset, from creating new products, engaging our employees, and improving our processes, we achieve success as individuals and as a company. We are action driven and hold each other accountable.


Everything we do is focused on helping patients heal faster…every day. From corporate development to customer relationships - sales and marketing, customer service, supply chain, manufacturing, administration, quality and regulatory, R & D and everything in between - every decision is made with our patients at the forefront.

Team focused

Through honesty, respect, inclusion and accountability, our employees form a. cohesive team. No single person is responsible for Isto's success, but each person makes the team stronger. We embrace each other's differences and help each other overcome weaknesses. Every day we come together to exceed both our goals and our customers' expectations.

Open minded

We must stay open-minded, embrace differences, and learn from our teammates and customers. Don't be afraid to make mistakes. Every stumble is a valuable opportunity for growth. Combining that with a continued quest for learning, will propel Isto forward with new ideas to respond to the ever-evolving needs of our patients.

The Isto Vision

Learn how it all started and where we are today.


Arteriocyte is formed



Arteriocyte Medical Systems is formed and Magellan PRP is introduced in cardiac & orthopedic setting

magellan autologous concentration system.png


TRU line Is brought to market

TruPRP Logo RGB_with white background


Arteriocyte and ISTO Tech merge forming Isto Biologics

isto navy and orange.png


InQu is added to the Isto portfolio



Isto expands into the allograft space by adding the Influx line



Influx SPARC is launched

influx sparc.png


Isto acquires TheraCell, inc. and launches Influx Fibrant


Interested in joining our team?

We'd love to have you on board.

Learn more →